Selmar Lab Profile
Key Indicators
- Authorised Capital ₹ 6.30 Cr
- Paid Up Capital ₹ 4.52 Cr
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 13.30%
- Profit Growth -49.63%
- Ebitda -48.86%
- Net Worth 22.82%
- Total Assets 26.79%
About Selmar Lab
Selmar Lab Private Limited (SLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 August 2013 and has a history of 11 years and six months. Its registered office is in Medak, Telangana, India.
The Corporate was formerly known as Selmar Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.30 Cr and a paid-up capital of Rs 4.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sambi Jonnala and Chandra Tumuluru serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2013PTC089489
- Company No.
089489
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2013
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Selmar Lab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sambi Jonnala  | Director | 31-Dec-2018 | Current |
| Chandra Tumuluru | Director | 31-Dec-2018 | Current |
Financial Performance of Selmar Lab.
Selmar Lab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.3% increase. The company also saw a substantial fall in profitability, with a 49.63% decrease in profit. The company's net worth Soared by an impressive increase of 22.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Selmar Lab?
In 2023, Selmar Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hindys Lab Private LimitedSambi Jonnala is a mutual person
Hetero Marbles Private LimitedChandra Tumuluru is a mutual person
Hetero Drugs LimitedSambi Jonnala is a mutual person
- Hetero Infrastructure Sez Private Limited
Sambi Jonnala is a mutual person
- Hetero Biopharma Limited
Chandra Tumuluru is a mutual person
Cirex Pharmaceuticals Private LimitedChandra Tumuluru is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Selmar Lab?
Selmar Lab has a workforce of 82 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Selmar Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Selmar Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
